Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV001025339 | SCV001187511 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-27 | criteria provided, single submitter | clinical testing | The p.M22V variant (also known as c.64A>G), located in coding exon 1 of the STK11 gene, results from an A to G substitution at nucleotide position 64. The methionine at codon 22 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
| Invitae | RCV001044306 | SCV001208096 | uncertain significance | Peutz-Jeghers syndrome | 2023-09-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 22 of the STK11 protein (p.Met22Val). This variant is present in population databases (no rsID available, gnomAD 0.01%). This missense change has been observed in individual(s) with breast and thyroid cancer (PMID: 30093976). ClinVar contains an entry for this variant (Variation ID: 826447). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function. |
| Genome- |
RCV001044306 | SCV002057727 | uncertain significance | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
| Baylor Genetics | RCV003461406 | SCV004205575 | uncertain significance | Melanoma, cutaneous malignant, susceptibility to, 1 | 2023-07-16 | criteria provided, single submitter | clinical testing |